Laurus Labs is coming out with an initial public offering (IPO) to raise up to Rs 300 crore in a price band Rs 426-428 per share. The issue will open for subscription on December 6, 2016 and will close on December 8, 2016.
Shares of the company are proposed to be listed on NSE and BSE both. The Book Running Lead Managers (BRLMs) to the offer are Kotak Mahindra Capital Company, Citigroup Global Markets India, Jefferies India and SBI Capital Markets. The firm proposes to use the net proceeds from the fresh issue towards pre-payment of term loans and general corporate purposes.
Laurus Labs is a leading research and development driven pharmaceutical company in India. The company has grown consistently to become one of the leading manufacturers of Active Pharmaceutical Ingredients (APIs) for anti-retroviral (ARV) and Hepatitis C. Laurus Labs also manufactures APIs in oncology and other therapeutic areas.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1841.50 |
Dr. Reddys Lab | 1355.15 |
Cipla | 1489.20 |
Lupin | 2181.60 |
Zydus Lifesciences | 959.55 |
View more.. |